Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
Axenio AG Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €1.20 |
52 Week High | €1.20 |
52 Week Low | €1.00 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | 14.29% |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 20.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
MK30 | DE Professional Services | DE Market | |
---|---|---|---|
7D | 0% | -5.0% | -3.1% |
1Y | n/a | -27.7% | -0.5% |
Return vs Industry: Insufficient data to determine how MK30 performed against the German Professional Services industry.
Return vs Market: Insufficient data to determine how MK30 performed against the German Market.
Price Volatility
MK30 volatility | |
---|---|
MK30 Average Weekly Movement | n/a |
Professional Services Industry Average Movement | 4.6% |
Market Average Movement | 5.0% |
10% most volatile stocks in DE Market | 10.3% |
10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: MK30 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MK30's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | n/a | www.axenio.com |
Axenio AG provides management consulting services. It focuses on corporate structure consulting and corporate research; the acquisition, sale, rental, and management of real estate; and the acquisition, management, and sale of assets. Axenio AG was formerly known as Hande Health AG.
Axenio AG Fundamentals Summary
MK30 fundamental statistics | |
---|---|
Market cap | €300.00k |
Earnings (TTM) | €0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs MK30 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MK30 income statement (TTM) | |
---|---|
Revenue | €0 |
Cost of Revenue | €0 |
Gross Profit | €0 |
Other Expenses | €0 |
Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did MK30 perform over the long term?
See historical performance and comparison